Humira vs Dupixent
Adalimumab vs Dupilumab · Comparison Guide
Quick Comparison
| Feature | Humira | Dupixent |
|---|---|---|
| Generic Name | Adalimumab | Dupilumab |
| Manufacturer | AbbVie | Sanofi/Regeneron |
| Drug Class | TNF-alpha Inhibitor | IL-4/IL-13 Inhibitor |
| Shared Conditions | Atopic Dermatitis, Asthma, Nasal Polyps, Eosinophilic Esophagitis | |
Key Differences: Humira vs Dupixent
These medications treat different conditions and are rarely directly compared. Dupixent is first-line for atopic dermatitis; Humira is not FDA-approved for eczema. For hidradenitis suppurativa, Humira is approved while Dupixent is not. Both are injectable biologics with strong copay programs available to insured patients.
💊 Humira (Adalimumab)
- Class: TNF-alpha Inhibitor
- Manufacturer: AbbVie
- Full Humira information →
💊 Dupixent (Dupilumab)
- Class: IL-4/IL-13 Inhibitor
- Manufacturer: Sanofi/Regeneron
- Full Dupixent information →
These medications treat different conditions and are rarely directly compared. Dupixent is first-line for atopic dermatitis; Humira is not FDA-approved for eczema. For hidradenitis suppurativa, Humira is approved while Dupixent is not. Both are injectable biologics with strong copay programs available to insured patients.
Neither Humira nor Dupixent is universally better — the right choice depends on your specific condition, disease severity, insurance formulary, and health history. Your prescriber will determine which is most appropriate based on your clinical situation. BiologicHealthPlus carries both and can help you compare your coverage and costs for either medication.
Switching between biologics is common. Your prescriber will evaluate your current treatment response and determine if a switch is appropriate. BiologicHealthPlus can coordinate the transition including prior authorization for your new medication.
Both Humira and Dupixent are covered by most commercial insurance plans, Medicare Part D, and Medicaid with prior authorization. BiologicHealthPlus handles insurance verification and prior authorization for both medications at no charge. Most insured patients pay $0–$35/month through manufacturer copay programs.
Humira and Dupixent both have high cash list prices ($4,000–$9,000/month range) but most commercially insured patients pay $0–$35/month through manufacturer savings programs. BiologicHealthPlus automatically enrolls every patient in all available savings programs at no charge.
✅ BiologicHealthPlus Carries Both Humira and Dupixent
We handle insurance verification, prior authorization, copay enrollment, and free cold-chain delivery for both medications. Contact us and we'll help you understand your options and costs.
Medical Disclaimer: This comparison is for educational purposes only. The choice between Humira and Dupixent should be made by your healthcare provider based on your specific medical history, disease severity, and individual circumstances. Last updated: July 2026.